Podiatrist Loses DEA Registration Over State License Issue
Published Date: 6/24/2026
Notice
Summary
Irina Gross, a podiatrist from Ohio, lost her DEA registration because she no longer has the state permission to handle controlled substances. She didn’t ask for a hearing, so the DEA canceled her registration by default. This means she can’t legally prescribe or manage controlled drugs anymore, effective immediately, impacting her medical practice and patients.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
DEA Registration Revoked for Named Podiatrist
The Drug Enforcement Administration revoked DEA Certificate of Registration No. FG2593487 issued to Irina Gross, D.P.M., because she no longer has state authority to handle controlled substances. The revocation is effective July 24, 2026; her Ohio DPM and RCP licenses were suspended effective June 11, 2025 and are recorded as permanently revoked in Ohio online records.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-15624, Amendment to 3,4-MDP-2-P Methyl Glycidic Acid, a List I Chemical
The Drug Enforcement Administration is proposing to modify the listing of the list I chemical 3,4-MDP-2-P methyl glycidic acid (also known as PMK glycidic acid) to include esters of 3,4-MDP-2-P methyl glycidic acid, not listed elsewhere in the Controlled Substances Act (CSA), as list I chemicals under the CSA. The current listing of 3,4- MDP-2-P methyl glycidic acid includes its salts, optical and geometric isomers, and salts of isomers. DEA proposes the new listing to read as follows: 3,4-MDP-2-P methyl glycidic acid (PMK glycidic acid) and its esters, not listed elsewhere in the CSA, its optical and geometric isomers, its salts, salts of its optical and geometric isomers, salts of its esters, not listed elsewhere in the CSA, and any combination thereof, whenever the existence of such is possible.
2026-15328, Joan Rubinger, N.P.; Decision and Order
2026-15199, Kerri Zavota, DVM; Decision and Order
2026-15201, Gene M. Koop, D.D.S.; Decision and Order
Previous / Next Documents
Previous: 2026-12649, Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee
The Department of Defense is holding a public meeting on June 22, 2026, to discuss updates to the Uniform Formulary, which affects military health beneficiaries and their medication options. This meeting will review recommendations that could change which medicines are covered, potentially impacting costs and access. Anyone interested can join by phone and share their thoughts, making it a great chance to have a say in military healthcare decisions.
Next: 2026-12651, Certain Frozen Fish Fillets From Vietnam; Determination
The U.S. International Trade Commission decided to keep the extra taxes on frozen fish fillets from Vietnam because removing them could hurt American fish businesses. This means importers will still pay these duties, helping protect U.S. jobs and companies. The decision was finalized in June 2026 and affects anyone buying or selling these fish fillets in the U.S.